Sarah Schott - Concepedia

Author

Sarah Schott

Also Known As

Christa Stegmaier, F Schütz, S SCHOTT, S Schott, S. Schott, Sarah Schott, Sarah Schott (146543), Saskia Schott, Schott, Sarah, Schott, Simon

299

Publications

4.7K

Citations

H-Index

127

Concepts

All Affiliations

Heidelberg University University Hospital Heidelberg German Cancer Research Center National Center for Tumor Diseases University of Tübingen

About

Sarah Schott is an author at Heidelberg University specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	38	2.3K
2	Health Sciences	5	5	171
3	Nursing	5	5	152
4	Engineering	3	3	177
5	Natural Sciences	1	1	17

Sarah Schott

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Topography of cancer-associated immune cells in human solid tumors Jakob Nikolas Kather, Meggy Suarez‐Carmona, Pornpimol Charoentong, eLife Immune EvasionCancer ImmunosurveillanceBivariate Classification SystemTumor HeterogeneityCancer-associated Immune Cells	2018	268
Circulating microRNAs in plasma as early detection markers for breast cancer Katarina Ćuk, Manuela Zucknick, Dharanija Madhavan, International Journal of Cancer Blood PlasmaEarly Detection MarkersOncologyMedicineBiomarker Target	2012	266
Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer Dharanija Madhavan, Manuela Zucknick, Markus Wallwiener, Clinical Cancer Research	2012	249
Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome Yingzi Ge, Christoph Domschke, Natalija Stoiber, Cancer Immunology Immunotherapy Immunological EffectsClinical OutcomeMetronomic Cyclophosphamide TreatmentBreast OncologyMedicine	2011	222
Prevalence of <i>BRCA1/2</i> germline mutations in 21 401 families with breast and ovarian cancer Karin Kast, Kerstin Rhiem, Barbara Wappenschmidt, Journal of Medical Genetics	2016	217
Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis Dharanija Madhavan, Markus Wallwiener, Karin Bents, Breast Cancer Research and Treatment Early DiagnosisBiomarker (Medicine)Metastatic Breast CancerOncologyBreast Oncology	2014	162
Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis Dharanija Madhavan, Cike Peng, Markus Wallwiener, Carcinogenesis Breast OncologyPrognosisPathologySixteen MirnasTumor Biology	2016	138
Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer Katarina Ćuk, Manuela Zucknick, Dharanija Madhavan, PLoS ONE Breast OncologyOncologyPlasma Microrna PanelCancer DetectionMedicine	2013	136
The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution Alexej Ballhausen, Moritz J. Przybilla, Michael Jendrusch, Nature Communications	2020	125
The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer Markus Wallwiener, Andreas D. Hartkopf, Irène Baccelli, Breast Cancer Research and Treatment Metastatic Breast CancerPrognostic ImpactBreast OncologyMedicinePathology	2012	110

Page 1